Progress and limitations of oral peptide delivery as a potentially transformative therapy

This publication has 80 references indexed in Scilit:

• Future directions for peptide therapeutics development
  Drug Discovery Today, 2013
• The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo
  Biomaterials, 2011
• Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer
  International Journal of Pharmaceutics, 2009
• Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin
  BMC Clinical Pharmacology, 2008
• A new concept in colonic drug targeting: a combined pH‐responsive and bacterially‐triggered drug delivery technology
  Alimentary Pharmacology & Therapeutics, 2008
• Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant
  European Journal of Pharmaceutics and Biopharmaceutics, 2006
• Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts
  Journal of Controlled Release, 2005
• The effect of ΔG on the transport and oral absorption of macromolecules
  Journal of Pharmaceutical Sciences, 2004
• Absorption Enhancing Effect of Labrasol on the Intestinal Absorption of Insulin in Rats
  Journal of Drug Targeting, 2002
• Site-Dependent Effect of Aprotinin, Sodium Caprate, Na2EDTA and Sodium Glycocholate on Intestinal Absorption of Insulin.
  Biological and Pharmaceutical Bulletin, 1993